Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioma 4Glioblastoma 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Positron Emission Tomography Computed Tomography 2fluciclovine F-18 1abemaciclib 1Valproic Acid 1Tetrahydrouridine 1Sirolimus 1Positron-Emission Tomography 1Oncolytic Virotherapy 1Metformin 1Magnetic Resonance Imaging 1Lapatinib 1Ferrosoferric Oxide 1Fatty Acids, Omega-3 1BCG Vaccine 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × fluciclovine F-18 × Clear all
NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Brigham and Women's Hospital

Phase EARLY_PHASE1 Active not recruiting
16 enrolled 3 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡